Literature DB >> 20922569

6q24 transient neonatal diabetes.

I Karen Temple1, Julian P H Shield.   

Abstract

Transient Neonatal Diabetes (type 1) is the commonest cause of diabetes presenting in the first week of life. The majority of infants recover by 3 months of age but are predisposed to developing type 2 diabetes in later life. It is associated with low birth weight but rapid catch up by 1 year of life. The condition is usually due to genetic or epigenetic aberrations at an imprinted locus on chromosome 6q24 and can be sporadic or inherited. Early diagnosis alters medical treatment strategies and differentiates it from other types of early onset diabetes. In some individuals, diabetes may be the initial presentation of a more complex imprinting disorder due to recessive mutations in the gene ZFP57 and may be associated with other developmental problems.

Entities:  

Mesh:

Year:  2010        PMID: 20922569     DOI: 10.1007/s11154-010-9150-4

Source DB:  PubMed          Journal:  Rev Endocr Metab Disord        ISSN: 1389-9155            Impact factor:   6.514


  35 in total

1.  Transcription of the mouse PAC1 receptor gene: cell-specific expression and regulation by Zac1.

Authors:  Nieves Rodríguez-Henche; Françoise Jamen; Céline Leroy; Joël Bockaert; Philippe Brabet
Journal:  Biochim Biophys Acta       Date:  2002-06-07

2.  A novel imprinted gene, HYMAI, is located within an imprinted domain on human chromosome 6 containing ZAC.

Authors:  T Arima; R A Drewell; M Oshimura; N Wake; M A Surani
Journal:  Genomics       Date:  2000-08-01       Impact factor: 5.736

3.  Congenital temporary diabetes mellitus.

Authors:  J H HUTCHISON; A J KEAY; M M KERR
Journal:  Br Med J       Date:  1962-08-18

4.  Genetic and epigenetic defects at the 6q24 imprinted locus in a cohort of 13 patients with transient neonatal diabetes: new hypothesis raised by the finding of a unique case with hemizygotic deletion in the critical region.

Authors:  C Diatloff-Zito; A Nicole; G Marcelin; H Labit; E Marquis; C Bellanné-Chantelot; J J Robert
Journal:  J Med Genet       Date:  2006-09-13       Impact factor: 6.318

Review 5.  LOT1 (ZAC1/PLAGL1) and its family members: mechanisms and functions.

Authors:  Abbas Abdollahi
Journal:  J Cell Physiol       Date:  2007-01       Impact factor: 6.384

6.  Transient neonatal diabetes: widening the understanding of the etiopathogenesis of diabetes.

Authors:  I K Temple; R J Gardner; D J Mackay; J C Barber; D O Robinson; J P Shield
Journal:  Diabetes       Date:  2000-08       Impact factor: 9.461

7.  KCNJ11 activating mutations are associated with developmental delay, epilepsy and neonatal diabetes syndrome and other neurological features.

Authors:  Anna L Gloyn; Catherine Diatloff-Zito; Emma L Edghill; Christine Bellanné-Chantelot; Sylvie Nivot; Régis Coutant; Sian Ellard; Andrew T Hattersley; Jean Jacques Robert
Journal:  Eur J Hum Genet       Date:  2006-05-03       Impact factor: 4.246

8.  Beta-cell dysfunction in classic transient neonatal diabetes is characterized by impaired insulin response to glucose but normal response to glucagon.

Authors:  Giuliana Valerio; Adriana Franzese; Mariacarolina Salerno; Gianluca Muzzi; Gaetano Cecere; Karen I Temple; Julian P Shield
Journal:  Diabetes Care       Date:  2004-10       Impact factor: 19.112

Review 9.  Neonatal and very-early-onset diabetes mellitus.

Authors:  Michel Polak; Julian Shield
Journal:  Semin Neonatol       Date:  2004-02

Review 10.  Neonatal diabetes mellitus: a disease linked to multiple mechanisms.

Authors:  Michel Polak; Hélène Cavé
Journal:  Orphanet J Rare Dis       Date:  2007-03-09       Impact factor: 4.123

View more
  25 in total

Review 1.  Neonatal Diabetes Mellitus: An Update on Diagnosis and Management.

Authors:  Michelle Blanco Lemelman; Lisa Letourneau; Siri Atma W Greeley
Journal:  Clin Perinatol       Date:  2017-12-16       Impact factor: 3.430

Review 2.  Role of DNA methylation in imprinting disorders: an updated review.

Authors:  Amr Rafat Elhamamsy
Journal:  J Assist Reprod Genet       Date:  2017-03-09       Impact factor: 3.412

3.  Multiple microRNAs within the 14q32 cluster target the mRNAs of major type 1 diabetes autoantigens IA-2, IA-2β, and GAD65.

Authors:  Liron Abuhatzira; Huanyu Xu; Georges Tahhan; Afroditi Boulougoura; Alejandro A Schäffer; Abner L Notkins
Journal:  FASEB J       Date:  2015-07-06       Impact factor: 5.191

Review 4.  Management of diabetes mellitus in infants.

Authors:  Beate Karges; Thomas Meissner; Andrea Icks; Thomas Kapellen; Reinhard W Holl
Journal:  Nat Rev Endocrinol       Date:  2011-11-29       Impact factor: 43.330

5.  Sulfonylurea challenge test in subjects diagnosed with type 1 diabetes mellitus.

Authors:  Maria S Remedi; Mareen Thomas; Colin G Nichols; Bess A Marshall
Journal:  Pediatr Diabetes       Date:  2017-01-23       Impact factor: 4.866

Review 6.  Diabetes mellitus and the β cell: the last ten years.

Authors:  Frances M Ashcroft; Patrik Rorsman
Journal:  Cell       Date:  2012-03-16       Impact factor: 41.582

Review 7.  Monogenic diabetes: a gateway to precision medicine in diabetes.

Authors:  Haichen Zhang; Kevin Colclough; Anna L Gloyn; Toni I Pollin
Journal:  J Clin Invest       Date:  2021-02-01       Impact factor: 14.808

8.  T2DM: Why Epigenetics?

Authors:  Delphine Fradin; Pierre Bougnères
Journal:  J Nutr Metab       Date:  2011-11-03

9.  Transient neonatal diabetes, ZFP57, and hypomethylation of multiple imprinted loci: a detailed follow-up.

Authors:  Susanne E Boonen; Deborah J G Mackay; Johanne M D Hahnemann; Louise Docherty; Karen Grønskov; Anna Lehmann; Lise G Larsen; Andreas P Haemers; Yves Kockaerts; Lutgarde Dooms; Dung Chí Vu; C T Bich Ngoc; Phuong Bich Nguyen; Olga Kordonouri; Frida Sundberg; Pinar Dayanikli; Vijith Puthi; Carlo Acerini; Ahmed F Massoud; Zeynep Tümer; I Karen Temple
Journal:  Diabetes Care       Date:  2012-11-12       Impact factor: 19.112

10.  Genetic and epigenetic mutations affect the DNA binding capability of human ZFP57 in transient neonatal diabetes type 1.

Authors:  Ilaria Baglivo; Sabrina Esposito; Lucia De Cesare; Angela Sparago; Zahra Anvar; Vincenzo Riso; Marco Cammisa; Roberto Fattorusso; Giovanna Grimaldi; Andrea Riccio; Paolo V Pedone
Journal:  FEBS Lett       Date:  2013-03-13       Impact factor: 4.124

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.